Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Blinded Tapering for Hypnotic Discontinuation

NCT04050176 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.

NCT NCT04050176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04050176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Blinded Tapering for Hypnotic Discontinuation
Lead sponsor
National Jewish Health
Phase
Phase 3
Overall status
Active, not recruiting
Start date
December 16, 2019
Completion date
June 30, 2026
Enrollment
260 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypnotic dependence among those with insomnia